J. P. Marie

2.1k total citations
59 papers, 1.5k citations indexed

About

J. P. Marie is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, J. P. Marie has authored 59 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 25 papers in Oncology and 22 papers in Molecular Biology. Recurrent topics in J. P. Marie's work include Acute Myeloid Leukemia Research (20 papers), Drug Transport and Resistance Mechanisms (13 papers) and Acute Lymphoblastic Leukemia research (13 papers). J. P. Marie is often cited by papers focused on Acute Myeloid Leukemia Research (20 papers), Drug Transport and Resistance Mechanisms (13 papers) and Acute Lymphoblastic Leukemia research (13 papers). J. P. Marie collaborates with scholars based in France, Netherlands and Italy. J. P. Marie's co-authors include R Zittoun, Daoping Zhou, F Viguié, Ollivier Legrand, M Cadiou, R Zittoun, D-C Zhou, Marion Baudard, Da-Cheng Zhou and Alain Delmer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Clinical Microbiology.

In The Last Decade

J. P. Marie

58 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. P. Marie France 21 673 672 661 341 183 59 1.5k
Jean‐Pierre Marie France 28 1.1k 1.6× 1.1k 1.6× 956 1.4× 474 1.4× 370 2.0× 77 2.5k
Daniel Steinbach Germany 26 497 0.7× 943 1.4× 1.1k 1.6× 412 1.2× 161 0.9× 69 2.3k
S. E. Salmon United States 19 533 0.8× 949 1.4× 625 0.9× 76 0.2× 151 0.8× 43 1.8k
Dianna S. Howard United States 17 900 1.3× 652 1.0× 1.2k 1.8× 191 0.6× 150 0.8× 66 2.3k
Jörgen Kristensen Sweden 18 404 0.6× 284 0.4× 364 0.6× 145 0.4× 115 0.6× 57 1.3k
Kevin J. Freise United States 22 904 1.3× 513 0.8× 730 1.1× 163 0.5× 528 2.9× 74 1.8k
Alicja Chybicka Poland 17 594 0.9× 279 0.4× 182 0.3× 182 0.5× 125 0.7× 100 1.2k
Jianmin Wang China 26 1.3k 2.0× 700 1.0× 820 1.2× 321 0.9× 429 2.3× 141 2.7k
Rachel E. Rau United States 21 718 1.1× 234 0.3× 794 1.2× 459 1.3× 217 1.2× 74 1.6k
Shuji Tohda Japan 22 516 0.8× 311 0.5× 914 1.4× 185 0.5× 179 1.0× 156 1.9k

Countries citing papers authored by J. P. Marie

Since Specialization
Citations

This map shows the geographic impact of J. P. Marie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. P. Marie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. P. Marie more than expected).

Fields of papers citing papers by J. P. Marie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. P. Marie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. P. Marie. The network helps show where J. P. Marie may publish in the future.

Co-authorship network of co-authors of J. P. Marie

This figure shows the co-authorship network connecting the top 25 collaborators of J. P. Marie. A scholar is included among the top collaborators of J. P. Marie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. P. Marie. J. P. Marie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonnet, Catherine, Jean Clairambault, Hitay Özbay, et al.. (2012). A new model of cell dynamics in Acute Myeloid Leukemia involving distributed delays. IFAC Proceedings Volumes. 45(14). 55–60. 13 indexed citations
2.
3.
Schlegel, L., et al.. (2002). Impact thérapeutique des bactériémies à streptocoques et à entérocoques chez des malades d'hématologie. Pathologie Biologie. 50(3). 169–177. 4 indexed citations
4.
Cornet, Muriel, Valérie Ugo, Thierry Jo Molina, et al.. (2001). A Case of Disseminated Aspergillosis with Thyroid Involvement. European Journal of Clinical Microbiology & Infectious Diseases. 20(5). 358–359. 3 indexed citations
5.
Zompì, Simona, O. Legrand, Didier Bouscary, et al.. (2000). Therapy‐related acute myeloid leukaemia after successful therapy for acute promyelocytic leukaemia with t(15;17): a report of two cases and a review of the literature. British Journal of Haematology. 110(3). 610–613. 25 indexed citations
6.
Viguié, F, Azzedine Aboura, Sylvie Ramond, et al.. (2000). Submicroscopic Insertion of RARα Gene into Chromosome 15 in Two Cases of Acute Promyelocytic Leukemia. Cancer Genetics and Cytogenetics. 119(2). 162–164. 11 indexed citations
7.
Legrand, Ollivier, R Zittoun, & J. P. Marie. (1999). Role of MRP1 in multidrug resistance in acute myeloid leukemia. Leukemia. 13(4). 578–584. 34 indexed citations
8.
Gurbuxani, Sandeep, D-C Zhou, Ghislaine Simonin, et al.. (1998). Expression of genes implicated in multidrug resistance in acute lymphoblastic leukemia in India. Annals of Hematology. 76(5). 195–200. 12 indexed citations
9.
Sonneveld, Pieter, J. P. Marie, C. Huisman, et al.. (1996). Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study.. PubMed. 10(11). 1741–50. 79 indexed citations
10.
Elalamy, Ismaı̈l, et al.. (1996). A fatal low-molecular-weight heparin-associated thrombocytopenia after hip surgery. Blood Coagulation & Fibrinolysis. 7(7). 665–671. 19 indexed citations
11.
Zhou, Daoping, R Zittoun, & J. P. Marie. (1995). Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia.. PubMed. 9(10). 1661–6. 99 indexed citations
12.
Zhou, Daoping, R Zittoun, & J. P. Marie. (1995). Homoharringtonine: an effective new natural product in cancer chemotherapy.. PubMed. 82(12). 987–95. 77 indexed citations
13.
Russo, Domenico, J. P. Marie, D-C Zhou, et al.. (1994). Evaluation of the Clinical Relevance of the Anionic Glutathione-S-Transferase (GSTπ) and Multidrug Resistance (mdr-1) Gene Coexpression in Leukemias and Lymphomas. Leukemia & lymphoma. 15(5-6). 453–468. 15 indexed citations
14.
Delmer, Alain, Frédéric Bauduer, Anne Vekhoff, et al.. (1994). Evaluation of Carboplatin as a Single Agent in Highly Refractory Acute Myeloid Leukemia. Leukemia & lymphoma. 15(3-4). 311–315. 3 indexed citations
15.
Bauduer, Frédéric, Alain Delmer, M Blanc, et al.. (1993). Treatment of Chronic Myelogenous Leukemia in Blast Crisis and- in Accelerated Phase with High- or Intermediate-dose Cytosine Arabinoside and Amsacrine. Leukemia & lymphoma. 10(3). 195–200. 10 indexed citations
16.
Zhou, Da-Cheng, et al.. (1992). Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods.. PubMed. 6(9). 879–85. 82 indexed citations
17.
Delmer, Alain, et al.. (1989). Multivariate analysis of prognostic factors in acute myeloid leukemia: value of clonogenic leukemic cell properties.. Journal of Clinical Oncology. 7(6). 738–746. 36 indexed citations
18.
Marie, J. P., et al.. (1988). In vitro sensitivity of clonogenic cells in resisting and relapsing patients with acute myelogenous leukaemia. British Journal of Cancer. 58(5). 570–574. 6 indexed citations
19.
Zittoun, R, et al.. (1987). Prognostic value of in vitro uptake and retention of cytosine arabinoside in acute myelogenous leukemia.. PubMed. 14(2 Suppl 1). 269–75. 9 indexed citations
20.
Zittoun, R, et al.. (1982). High doses of cytosine arabinoside (HD-Ara-C) as reinforcement during remission of acute myeloid leukemia. Medical and Pediatric Oncology. 10(S1). 259–261. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Pierre Marie Breakdown of academic impact, for papers by Daniel Steinbach Breakdown of academic impact, for papers by S. E. Salmon Breakdown of academic impact, for papers by Dianna S. Howard Breakdown of academic impact, for papers by Jörgen Kristensen Breakdown of academic impact, for papers by Kevin J. Freise Breakdown of academic impact, for papers by Alicja Chybicka Breakdown of academic impact, for papers by Jianmin Wang Breakdown of academic impact, for papers by Rachel E. Rau Breakdown of academic impact, for papers by Shuji Tohda
Rankless by CCL
2026